← ANALYSTS · TIPRANKS
Thomas Shrader · BTIG
Hits
39%
194 of 492 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+6.6%
Over a year after the rating, TipRanks’ measure
Our companies rated now
18
Buy / hold / sell: 17 / 1 / 0
Upside of the analyst’s targets
+282.7%
Average over 17 current targets, to the last price
The market’s answer to the ratings
+1.9%
Day-0 move against SPY in the rating’s direction, average over 2 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 13on TipRanks Oct 14 06:15 | ALECIWMAlector · $213M | Reiterated | Buy | $6.00 | +226.1% | −10.1%next day +1.6% | ↗ |
| Oct 12on TipRanks 09:30 | STOKIWMStoke Therapeutics · $1.6B | Reiterated | Buy | $39.00 | +61.4% | −2.3%next day −6.8% | ↗ |
| Oct 5on TipRanks Oct 6 05:55 | ALECIWMAlector · $213M | Reiterated | Buy | $6.00 | +226.1% | +9.3%next day −9.6% · 5 days +4.1% | ↗ |
| Oct 5on TipRanks 09:10 | TLSATiziana Life Sciences · $144M | Reiterated | Buy | $7.00 | +566.7% | −5.1%next day +3.2% · 5 days +1.4% | ↗ |
| Oct 1on TipRanks Oct 2 06:16 | ARCTIWMArcturus Therapeutics · $320M | Reiterated | Buy | $20.00 | +93.4% | −3.7%next day −2.1% · 5 days −3.9% | ↗ |
| Sep 29on TipRanks Sep 30 06:30 | IVVDIWMInvivyd · $197M | Reiterated | Buy | $10.00 | +1,518.1% | −10.3%next day +2.6% · 5 days −7.1% | ↗ |
| Sep 24on TipRanks 07:20 | ARCTIWMArcturus Therapeutics · $320M | Reiterated | Buy | $23.00 → $20.00−13.0% | +93.4% | +6.2%next day −2.5% · 5 days −6.0% | ↗ |
| Sep 16on TipRanks Sep 17 05:50 | ABOSIWMAcumen Pharmaceuticals · $126M | Reiterated | Buy | $8.00 | +373.4% | −9.2%next day −2.7% · 5 days −13.8% | ↗ |
| Sep 9on TipRanks Sep 10 06:10 | IRDIWMOpus Genetics · $337M | Reiterated | Buy | $12.00 | +212.5% | +32.5%next day +6.5% · 5 days −4.5% | ↗ |
| Aug 25on TipRanks Aug 26 06:50 | HROWIWMHarrow Health · $1.1B | Reiterated | Buy | $63.00 | +130.9% | +3.5%next day −4.9% · 5 days −10.0% | ↗ |
| Aug 13on TipRanks 06:25 | ANROIWMAlto Neuroscience, Inc. · $888M | Assigned | Buy | $28.00 → $37.00+32.1% | +68.6% | +10.0%next day −0.3% · 5 days +8.0% | ↗ |
| Aug 11on TipRanks Aug 12 07:30 | COYACoya Therapeutics, Inc. · $105M | Reiterated | Buy | $16.00 | +276.5% | +3.8%next day −2.5% · 5 days +2.9% | ↗ |
| Aug 6on TipRanks Aug 7 07:10 | DNLIIWMDenali Therapeutics · $2.9B | Reiterated | Buy | $39.00 | +121.5% | +1.4%next day −0.2% · 5 days −0.8% | ↗ |
| Aug 5on TipRanks Aug 3 07:31 | BIOAIWMBioAge Labs, Inc. · $249M | Reiterated | Buy | $40.00 | +726.4% | +17.8%next day +2.1% · 5 days +4.2% | ↗ |
| Aug 3on TipRanks Aug 4 07:56 | STOKIWMStoke Therapeutics · $1.6B | Reiterated | Buy | $39.00 | +61.4% | +1.0%next day +5.3% · 5 days +7.0% | ↗ |
| Jul 29on TipRanks Jul 30 06:15 | PCVXIWMVaxcyte · $10.3B | Reiterated | Buy | $89.00 | +39.9% | −1.4%next day +3.9% · 5 days 0.0% | ↗ |
| Jul 13on TipRanks Jul 14 06:50 | BIIBSPYBiogen · $34.8B | Reiterated | Hold | — | — | +5.7%next day −8.5% · 5 days −3.4% | ↗ |
| Jun 11on TipRanks Jun 12 05:55 | NVAXIWMNovavax · $2.1B | Reiterated | Buy | $19.00 | +68.7% | +3.8%next day −2.2% · 5 days −0.4% | ↗ |
| Apr 2on TipRanks Apr 6 12:40 | ALECIWMAlector · $213M | Reiterated | Buy | $6.00 | +226.1% | −4.8%next day −3.2% · 5 days −1.9% | ↗ |
| Mar 30on TipRanks 05:55 | DRUGIWMBright Minds Biosciences · $535M | Reiterated | Buy | $147 | +186.5% | −2.0%next day +3.7% · 5 days +8.0% | ↗ |
| Mar 26on TipRanks Mar 27 07:15 | OVIDIWMOvid Therapeutics · $428M | Reiterated | Buy | $4.00 | +86.0% | +4.3%next day −4.8% · 5 days −12.2% | ↗ |
| Nov 17on TipRanks Nov 18 07:50 | BHVNIWMBiohaven Ltd. · $1.7B | Reiterated | Buy | $16.00 | +48.4% | +0.6%next day +15.1% · 5 days +16.6% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗